In light of recent data from ASCO 2019 and the NEJM, would you recommend induction chemotherapy or an adjuvant approach in combination with chemoradiation for locally advanced nasopharyngeal carcinoma?
Does your approach differ by EBV status?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Florida Cancer Specialists
Answered on · Updated on
Definitely, and yes mainly for EBV positive tumors.
That trial certainly provides not only rationale for using induction Cis-Gemcitabine, but also the little role left of adjuvant therapy.
Join for free or sign in to see the full answer